Related Experiment Videos
The accuracy of portable cholesterol analyzers in public screening programs
M J Naughton1, R V Luepker, D Strickland
1Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis 55455.
JAMA
|March 2, 1990
Summary
Portable cholesterol analyzers used in public screenings often yield inaccurate results, with three out of four organizations falling outside acceptable ranges. These finger-stick tests may underestimate cholesterol levels, leading to false-negative risk assessments.
Area of Science:
- Clinical Chemistry
- Public Health Screening
- Diagnostic Accuracy Studies
Background:
- Accurate cholesterol measurement is crucial for cardiovascular disease risk assessment.
- Portable analyzers are increasingly used in community settings for cholesterol screening.
- Ensuring the reliability of these point-of-care devices is essential for public health.
Purpose of the Study:
- To evaluate the accuracy of portable cholesterol analyzers in real-world public screening environments.
- To compare finger-stick blood cholesterol measurements with reference laboratory values.
- To identify factors contributing to inaccuracies in public cholesterol screenings.
Main Methods:
- Four organizations conducting public cholesterol screenings were observed.
- Participant finger-stick blood samples were analyzed using portable devices.
- Finger-stick results were compared against venous blood samples analyzed by a reference laboratory.
- Data were analyzed for accuracy within +/- 14.2% and National Cholesterol Education Program risk category classification.
Main Results:
- Only one of the four organizations achieved cholesterol measurements within the acceptable accuracy range.
- The accuracy for the other three organizations ranged from 76.5% to 96.4%.
- Inaccurate finger-stick results frequently underestimated laboratory cholesterol values, leading to false-negative risk classifications.
Conclusions:
- Portable cholesterol analyzers in public settings demonstrate variable accuracy, with a significant tendency towards underestimation.
- Insufficient operator training, inadequate quality control, and blood dilution by tissue fluid contribute to inaccurate results.
- The findings highlight the need for improved standardization and quality assurance for public cholesterol screening programs.